# Aura Biosciences, Inc.: Form 10-Q for the period ended Sep 30, 2021

- Company: [Aura Biosciences, Inc.](/companies/aura.md) (CIK 1501796)
- Form: 10-Q
- Filed: 2021-11-24
- Accepted by EDGAR: Nov 24, 2021, 16:21 ET
- Period: 2021-09-30
- Accession: 0000950170-21-004908
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1501796/000095017021004908/aura-20210930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501796/000095017021004908/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 3 months, 2021-07-01 to 2021-09-30 | $6.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2021-01-01 to 2021-09-30 | $17.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2021-07-01 to 2021-09-30 | −$8.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2021-01-01 to 2021-09-30 | −$23.6m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months, 2021-07-01 to 2021-09-30 | −$8.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2021-01-01 to 2021-09-30 | −$23.6m | us-gaap:NetIncomeLoss |
| Operating cash flow | 9 months, 2021-01-01 to 2021-09-30 | −$20.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2021-01-01 to 2021-09-30 | $1.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2021-09-30 | $81.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-09-30 | $83.5m | us-gaap:AssetsCurrent |
| Total assets | at 2021-09-30 | $90.7m | us-gaap:Assets |
| Current liabilities | at 2021-09-30 | $5.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2021-09-30 | $6.4m | us-gaap:Liabilities |
| Shareholders' equity | at 2021-09-30 | −$131.0m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1501796/000095017021004908/aura-20210930.htm

Filed Nov 24, 2021.
Source: SEC EDGAR, the filing index for accession 0000950170-21-004908. Last ingested by Listed: Nov 14, 2026, 18:49 ET. No prices; not investment advice.
